Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical deterioration | clinical improvement | deaths | PCR-negative conversion | |||
| Immunostimulants drugs | - | - | - | OBS 715.00 [12.94; 39513.71], 1 study, I2=0% unassessable degree of certainty | ||
| A EFFACER anticorps | 0 | - | - | - | - | |
| acalabrutinib | 0 | - | - | - | - | |
| anti-inflammatory therapies | 0 | - | - | - | - | |
| Apilimod | 0 | - | - | - | - | |
| corticosteroids | 0 | - | - | - | - | |
| imatinib | 0 | - | - | - | - | |
| Immunosuppressants drugs | 0 | - | - | - | - | |
| leflunomide | 0 | - | - | - | - | |
| pirfenidone | 0 | - | - | - | - | |
| Polyinosinic-Polycytidylic Acid | 0 | - | - | - | - | |
| sargramostim | 0 | - | - | - | - | |
| thymosin | 0 | - | - | - | - | |
-
About us
-
Contact us
-
Method
Made with in Lyon
-
Credits
-
Privacy policy
-
